| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2012-10-08 | Delphi Genetics (Belgium) Merck&Co (USA) | StabyExpress™ system | licensing |
Licensing agreement | ||
| 2012-10-05 | Veloxis Pharmaceuticals (Denmark) Chiesi Farmaceutici (italy) | LCP-Tacro™ | distribution |
Transplantation | Distribution agreement | |
| 2012-10-04 | Cenix Biosciences (Germany) Ugichem (Austria) | R&D |
R&D agreement | |||
| 2012-10-04 | Medicago (Canada) Cellectis (France) | biosimilar therapeutic proteins expressed from tobacco leaves | R&D |
R&D agreement | ||
| 2012-10-04 | iNovacia (Sweden) Intellect Neurosciences (USA) | preclinical compounds for the drug optimization and selection program for Intellect’s antibody drug conjugate (ADC), CONJUMAB-A | age related macular degeneration | R&D |
Ophtalmological diseases | R&D agreement |
| 2012-10-04 | arGEN-X (The Netherlands-Belgium) RuiYi (formerly Anaphore) (USA-China) | ARGX-109 | cancer, autoimmune diseases | development |
Cancer - Oncology, Autoimmune diseases | Development agreement |
| 2012-10-03 | Leo Pharma (Denmark) Charité (Germany) | dermatological treatment solutions | psoriasis, atopic dermatitis, actinic keratosis, new undisclosed therapeutic areas for LEO Pharma | R&D |
Autoimmune diseases - Dermatological diseases | R&D agreement |
| 2012-10-03 | Icon (Ireland) Korea National Enterprise for Clinical Trials (KoNECT) (South Korea) | educational events | clinical research |
Clinical research agreement | ||
| 2012-10-03 | Gentium (Italy) Biologix FZCo (United Arab Emirates) | defibrotide | prevention and treatment of hepatic veno-occlusive disease (VOD) | distribution |
Digestive diseases - Liver diseases - Transplantation | Distribution agreement |
| 2012-10-03 | Oramed Pharmaceuticals (Israel) Medpace (USA) | ORMD-0801 (oral insulin capsule) | diabetes | clinical research |
Metabolic diseases | Clinical research agreement |
| 2012-10-02 | Theravance (USA) Alfa Wassermann (Italy) | velusetrag (TD-5108) | gastroparesis, gastrointestinal motility disorders | development |
Gastrointestinal diseases - Digestive diseases | Development agreement |
| 2012-09-28 | Evotec (Germany) Aspireo Pharmaceuticals (Israel) | somatoprim (DG3173 - somatostatin analogue) | acromegaly, carcinoid tumours, Cushing’s disease, diabetic retinopathy | services |
Cancer - Oncology - Ophtalmological diseases - Rare diseases | Services contract |
| 2012-09-27 | Lonza (Switzerland) Intellect Neurosciences (USA) | CONJUMAB-A | age-related macular degeneration, Alzheimer’s disease | development |
Neurodegenerative diseases - Ophtalmological diseases | Production agreement |
| 2012-09-27 | Curetis (Germany) BioLine (UK) | Unyvero™ Solution and the Unyvero™ P50 Pneumonia | pneumonia, infectious diseases | distribution |
Infectious diseases | Distribution agreement |
| 2012-09-27 | MAB Discovery (Germany) undisclosed US oncology focused biotech (USA) | monoclonal antibodies | R&D |
Cancer - Oncology | R&D agreement | |
| 2012-09-27 | MAB Discovery (Germany) undisclosed top 20 pharmaceutical company | monoclonal antibodies | undisclosed | R&D |
undisclosed | R&D agreement |
| 2012-09-27 | NeuroSearch (Denmark) Teva Pharmaceutical (Israel) | Huntexil® (pridopidine / ACR16) | Huntington disease | product acquisition | Genetic diseases - Neurodegenerative diseases - Rare diseases | Product acquisition |
| 2012-09-27 | Ipsen (France) Genosplice (France) | bioinformatics analysis of genes splicing | services |
Services contract | ||
| 2012-09-26 | Curetis (Germany) Mediphos Medical Supplies (The Netherlands) | Unyvero™ Solution and the Unyvero™ P50 Pneumonia Application | pneumonia, infectious diseases | distribution |
Infectious diseases | Distribution agreement |
| 2012-09-26 | Pluristem Therapeutics (Israel) Fisher BioServices (USA) | PLX cells - PLacental eXpanded (PLX) cells | Services contract |
